Safety and pharmacokinetics of oral and longacting injectable cabotergravir or longacting rilpivirine in virologically supressed adolescents with HIV IMPAACT 2017MOCHAaa phase 12 multicentre openlebel noncomparative dosefinding study

Aditya GuarE Capparellik calabresek baltrusaitisFaeezah Patel2025-01-212025-01-21WOS2352-3018https://hdl.handle.net/10539/43571Safety and pharmacokinetics of oral and longacting injectable cabotergravir or longacting rilpivirine in virologically supressed adolescents with HIV IMPAACT 2017MOCHAaa phase 12 multicentre openlebel noncomparative dosefinding studyJournal Article